Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Three Fraction Radiation to Induce Immuno-Oncologic Response

Patients with high risk breast cancers (any locally advanced breast cancer patient defined as Stages IIB-III [excluding inflammatory breast cancer] with stage IIA being eligible for triple

  • 0 views
  • 25 Jan, 2021
  • 1 location
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Study objective: To quantify the uptake of 68GaNOTA-Anti-HER2 VHH1 in local or distant metastases from breast carcinoma patients and to assess repeatability of the image-based HER2 quantification. The uptake will be correlated to results obtained via biopsy of the same lesion, if available. Time schedule: After inclusion, patients will be …

  • 0 views
  • 25 Jan, 2021
  • 1 location
The p53 Breast Cancer Trial

disease, and treated with dose-dense cyclphosphamide. Furthermore, patients included are stratified based on tumor stage; i.e. locally advanced breast cancer (M0 disease) or metastatic breast cancer (M1

  • 20 views
  • 24 Jan, 2021
  • 5 locations
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

This phase I/II trial studies the side effect and best dose of neratinib and to see how well it works with paclitaxel and with or without pertuzumab and trastuzumab before combination chemotherapy in treating patients with breast cancer that has spread to other places in the body (metastatic). Neratinib may …

ejection fraction
carcinoma
probe
advanced breast cancer
erythema
  • 12 views
  • 28 Mar, 2021
  • 2 locations
Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer

docetaxel given as neoadjuvant treatment in HER2 positive early stage or locally advanced breast cancer.

ejection fraction
docetaxel
advanced breast cancer
breast cancer
cancer
  • 20 views
  • 22 Jan, 2021
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

This study was designed to evaluate the efficacy and safety of pyrotinib combined with albumin paclitaxel and trastuzumab in the treatment of Her2-positive early or locally advanced breast

paclitaxel
advanced breast cancer
tumor cells
erbb2
locally advanced breast cancer
  • 33 views
  • 23 Jan, 2021
Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in Patients With HER2 Positive Breast Cancer

of neoadjuvant pyrotinib and trastuzumab plus docetaxel given as neoadjuvant treatment in HER2 positive early stage or locally advanced breast cancer.

her1
docetaxel
advanced breast cancer
metastasis
breast cancer
  • 0 views
  • 24 Jan, 2021
  • 1 location
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

trastuzumab plus docetaxel and Carboplatin given as neoadjuvant treatment in HER2 positive early stage or locally advanced breast cancer.

ejection fraction
docetaxel
advanced breast cancer
breast cancer
cancer
  • 15 views
  • 24 Jan, 2021
  • 1 location
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer

This is an open label, randomized, multicenter, international phase II study for premenopausal patients with hormone receptor positive, HER2 negative metastatic or locally advanced breast cancer

  • 0 views
  • 23 Jan, 2021
  • 1 location
Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

to treat hormone receptor-positive/human epidermal growth factor receptor 2-negative locally advanced breast cancer or metastatic breast cancer. This brings more treatment options for hormone

  • 0 views
  • 23 Jan, 2021
  • 3 locations